FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2300968907> ?p ?o ?g. }

• W2300968907 abstract "Infantile hemangiomas (IHs) are the most common benign tumors affecting infants, and most IHs are self-limiting. However, there are cases that require specific treatment. Propranolol is now widely used to treat severe IHs. Several studies have shown the efficacy and limited side effects associated with propranolol as the first-line treatment for IHs. There are a limited number of publications describing the role of propranolol in treating IHs beyond the proliferative phase (>12 months). The purpose of this study was to evaluate the effects and safety of oral high-dose (2.0 mg/kg per day) propranolol for IHs beyond the proliferative phase (>12 months).This study enrolled patients with IHs who accepted systemic propranolol treatment from the Department of Oral and Maxillofacial Surgery, Stomatological Hospital Affiliated China Medical University. This is a single-center retrospective study conducted from April 2011 to July 2015. All children who were older than 12 months were eligible for the study. Digital photographs taken before and after treatment were analyzed by a panel of 3 plastic surgeons. The esthetic results were evaluated using a 4-point scale and ranked as poor, moderate, good, or excellent. The patient follow-up visits were scheduled monthly, and changes in the size, texture, and color of the lesions were recorded. The adverse effects after medication were evaluated and managed accordingly.We collected data on 31 eligible patients. The 31 patients had 32 hemangiomas (1 female patient had 2 lesions) and were treated with systemic propranolol at a high dose of 2 mg/kg per day. The mean age at the initiation of propranolol therapy was 18.4 months (range, 12 to 48 months), and the mean treatment duration was 10.1 months (range, 8 to 16 months). The treatment responses for the 32 hemangiomas included 17 excellent responses (53.1%), 8 good responses (25%), and 7 moderate responses (21.9%). There were no severe side effects encountered and recurrence was observed in 3 patients during the treatment and follow-up course.Oral propranolol, 2 mg/kg per day, is a safe and effective treatment for IHs beyond the proliferative phase (>12 months of age) in the Chinese population." @default.
• W2300968907 created "2016-06-24" @default.
• W2300968907 creator A5003051561 @default.
• W2300968907 creator A5006206833 @default.
• W2300968907 creator A5033139608 @default.
• W2300968907 creator A5039072735 @default.
• W2300968907 creator A5048610620 @default.
• W2300968907 creator A5052429576 @default.
• W2300968907 date "2016-08-01" @default.
• W2300968907 modified "2023-10-06" @default.
• W2300968907 title "Oral Propranolol for the Treatment of Infantile Hemangiomas in the Post-Proliferative Phase: A-Single Center Retrospective Study of 31 Cases" @default.
• W2300968907 cites W1580015953 @default.
• W2300968907 cites W1920554560 @default.
• W2300968907 cites W1963910752 @default.
• W2300968907 cites W1966787407 @default.
• W2300968907 cites W1970269068 @default.
• W2300968907 cites W1971918464 @default.
• W2300968907 cites W1977602557 @default.
• W2300968907 cites W1991951767 @default.
• W2300968907 cites W2002309639 @default.
• W2300968907 cites W2012270031 @default.
• W2300968907 cites W2022406683 @default.
• W2300968907 cites W2036405357 @default.
• W2300968907 cites W2037247287 @default.
• W2300968907 cites W2043760123 @default.
• W2300968907 cites W2050620531 @default.
• W2300968907 cites W2050888665 @default.
• W2300968907 cites W2051372744 @default.
• W2300968907 cites W2051838080 @default.
• W2300968907 cites W2070051206 @default.
• W2300968907 cites W2095779896 @default.
• W2300968907 cites W2101325544 @default.
• W2300968907 cites W2107603505 @default.
• W2300968907 cites W2113398862 @default.
• W2300968907 cites W2116932780 @default.
• W2300968907 cites W2125087480 @default.
• W2300968907 cites W2141812423 @default.
• W2300968907 cites W2167734599 @default.
• W2300968907 cites W2317232446 @default.
• W2300968907 cites W2320277402 @default.
• W2300968907 doi "https://doi.org/10.1016/j.joms.2016.03.004" @default.
• W2300968907 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27055227" @default.
• W2300968907 hasPublicationYear "2016" @default.
• W2300968907 type Work @default.
• W2300968907 sameAs 2300968907 @default.
• W2300968907 citedByCount "6" @default.
• W2300968907 countsByYear W23009689072017 @default.
• W2300968907 countsByYear W23009689072018 @default.
• W2300968907 countsByYear W23009689072020 @default.
• W2300968907 countsByYear W23009689072021 @default.
• W2300968907 countsByYear W23009689072023 @default.
• W2300968907 crossrefType "journal-article" @default.
• W2300968907 hasAuthorship W2300968907A5003051561 @default.
• W2300968907 hasAuthorship W2300968907A5006206833 @default.
• W2300968907 hasAuthorship W2300968907A5033139608 @default.
• W2300968907 hasAuthorship W2300968907A5039072735 @default.
• W2300968907 hasAuthorship W2300968907A5048610620 @default.
• W2300968907 hasAuthorship W2300968907A5052429576 @default.
• W2300968907 hasBestOaLocation W23009689071 @default.
• W2300968907 hasConcept C126322002 @default.
• W2300968907 hasConcept C141071460 @default.
• W2300968907 hasConcept C167135981 @default.
• W2300968907 hasConcept C197934379 @default.
• W2300968907 hasConcept C2778151854 @default.
• W2300968907 hasConcept C2780073493 @default.
• W2300968907 hasConcept C3019900241 @default.
• W2300968907 hasConcept C71924100 @default.
• W2300968907 hasConceptScore W2300968907C126322002 @default.
• W2300968907 hasConceptScore W2300968907C141071460 @default.
• W2300968907 hasConceptScore W2300968907C167135981 @default.
• W2300968907 hasConceptScore W2300968907C197934379 @default.
• W2300968907 hasConceptScore W2300968907C2778151854 @default.
• W2300968907 hasConceptScore W2300968907C2780073493 @default.
• W2300968907 hasConceptScore W2300968907C3019900241 @default.
• W2300968907 hasConceptScore W2300968907C71924100 @default.
• W2300968907 hasLocation W23009689071 @default.
• W2300968907 hasLocation W23009689072 @default.
• W2300968907 hasOpenAccess W2300968907 @default.
• W2300968907 hasPrimaryLocation W23009689071 @default.
• W2300968907 hasRelatedWork W2079880922 @default.
• W2300968907 hasRelatedWork W2093066673 @default.
• W2300968907 hasRelatedWork W2113695375 @default.
• W2300968907 hasRelatedWork W2282210535 @default.
• W2300968907 hasRelatedWork W2530959278 @default.
• W2300968907 hasRelatedWork W2954294567 @default.
• W2300968907 hasRelatedWork W3030044343 @default.
• W2300968907 hasRelatedWork W3031930117 @default.
• W2300968907 hasRelatedWork W3209300057 @default.
• W2300968907 hasRelatedWork W4220696190 @default.
• W2300968907 isParatext "false" @default.
• W2300968907 isRetracted "false" @default.
• W2300968907 magId "2300968907" @default.
• W2300968907 workType "article" @default.